UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 22 von 2754
Datensatz exportieren als...
BibTeX
Molecular testing for thyroid nodules: Review and current state
Cancer, 2018-03, Vol.124 (5), p.888-898
Roth, Mara Y.
Witt, Robert L.
Steward, David L.
2018
Volltextzugriff (PDF)
Details
Autor(en) / Beteiligte
Roth, Mara Y.
Witt, Robert L.
Steward, David L.
Titel
Molecular testing for thyroid nodules: Review and current state
Ist Teil von
Cancer, 2018-03, Vol.124 (5), p.888-898
Ort / Verlag
United States: Wiley Subscription Services, Inc
Erscheinungsjahr
2018
Quelle
Free E-Journal (出版社公開部分のみ)
Beschreibungen/Notizen
Thyroid nodules affect nearly two‐thirds of the world population. Fine‐needle biopsy with cytologic evaluation remains the diagnostic test of choice to distinguish benign from malignant thyroid nodules yet fails to discriminate as benign or malignant in up to one‐third of cases. This review discusses the limitation of current cytopathologic evaluation, the development of thyroid molecular testing, and the strengths and limitations of commercially available tests. Initial cytomolecular testing sought to identify specific gene mutations associated with thyroid cancer. Although the presence of a mutation was strongly associated with cancer, the likelihood of identifying a mutation was low; therefore, the test had low sensitivity. Subsequent tests developed have sought to improve the accuracy of cytomolecular testing for thyroid fine‐needle aspirations, both to reassure patients and providers when malignancy may be absent and to confirm the malignancy when present. The development of cytomolecular testing for thyroid nodules has informed and improved current understanding of thyroid nodule formation and progression. When used appropriately and with clear understanding of the advantages and disadvantages, cytomolecular testing has the potential to improve patient care in the setting of indeterminate thyroid nodules by helping to guide both the need for and the extent of thyroid surgery. Cancer 2018;124:888‐98. © 2017 American Cancer Society. Thyroid nodules affect nearly two‐thirds of the world population. Cytology alone, in the form of fine‐needle aspiration, fails to classify thyroid nodules in up to one‐third of cases. This review investigates the limitation of current evaluation techniques and the development of thyroid molecular testing, and it specifically discusses the strengths and limitations of currently available molecular tests.
Sprache
Englisch
Identifikatoren
ISSN: 0008-543X
eISSN: 1097-0142
DOI: 10.1002/cncr.30708
Titel-ID: cdi_proquest_miscellaneous_1980535635
Format
–
Schlagworte
Benign
,
Biopsy
,
Cancer
,
cytology
,
diagnosis
,
Diagnostic systems
,
Evaluation
,
Malignancy
,
Medical diagnosis
,
molecular testing
,
Mutation
,
Nodules
,
Oncology
,
Surgery
,
Thyroid
,
Thyroid cancer
,
Thyroid gland
,
thyroid nodules
,
World population
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX